CNMDCONMED Corporation

$44.43-11% 1Y

The financials

CONMED Corporation by the numbers

CONMED Corporation (CNMD) reported revenue of $343M in Q2 2026 (quarter ended Jun 30, 2026), up 0.3% from the same quarter a year earlier. That came with a gross margin of 57% and net income of $23M (6.7% of revenue). For the full year FY2025, revenue was $1.37B (+5.2% year on year) and net income $47M. Its largest region in Q2 2026 was United States at $52M, 34% of the disclosed total, ahead of EMEA at 26%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.

CONMED Corporation income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$343M$342M+0.3%
Gross profit$197M$188M+4.9%
Operating income$36M$38M−4.6%
Net income$23M$21M+7.7%
Diluted EPS$0.77$0.69+12%
Revenue by region, Q2 2026, as reported to the SEC
GeographicRevenueShare
United States$52M34%
EMEA$40M26%
Asia Pacific$37M24%
Americasexcludingthe United States$24M16%

Business segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Jun 2026Total $152.3M (+3.2%)
Asia Pacific grew +15% year on yearUnited States -0.07% year on year
  • United States$51.7Mquarter on quarter -7.7%year on year -0.07%
  • EMEA$40.3Mquarter on quarter +4.7%year on year +13%
  • Asia Pacific$36.6Mquarter on quarter +19%year on year +15%
  • Americasexcludingthe United States$23.8Mquarter on quarter +6.2%year on year +9.5%
Segment sum = 44% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed Jul 29, 2026, SEC EDGAR